John P. Longenecker Ph.D., Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 2,500 shares at $55.55 ($139K) on 2013-12-30, disclosed to the SEC on 2014-01-02.
Scheduled sale ($139k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | SELL | 2019-12-04 | $60K | — | Filing → |
| ALRN | BUY | 2018-08-14 | $25K | — | Filing → |
| PCRX | BUY | 2016-01-14 | $20K | — | Filing → |